From: Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children
UniProt accession | Gene name | Protein name | Trend | Associated with RMS | Associated with muscular tissue | Reported as urine biomarkers | Reported as cancer biomarkers |
---|---|---|---|---|---|---|---|
P09237 | MMP7 | Matrilysin | Up |  ×  |  ×  | IgA, kidney fibrosis | Colon cancer, cervical cancer, gastric cancer, bladder cancer, ovarian cancer, oral verrucous and squamous cell cancer, head and neck squamous cell carcinomas |
Q13938 | CAPS | Calcyphosin | Up |  ×  |  ×  |  ×  | Pediatric primitive neuroectodermal tumors, breast cancer, lung cancer |
P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | Up |  ×  | √ |  ×  | Hepatocellular carcinoma, gastric cancer, colorectal cancer |
P30086 | PEBP1 | Phosphatidylethanolamine-binding protein 1 | Up |  ×  |  ×  | Prostate cancer, ovarian cancer, clear cell renal cell carcinoma | Bladder cancer, pancreatic cancer, lung adenocarcinoma, hepatocellular carcinoma |
Q07075 | ENPEP | Glutamyl aminopeptidase | Up |  ×  |  ×  | Familial Parkinson's disease | Colorectal cancer, breast cancer |
Q24JP5 | TMEM132A | Transmembrane protein 132A | Up |  ×  |  ×  |  ×  |  ×  |
Q9H6S3 | EPS8L2 | Epidermal growth factor receptor kinase substrate 8-like protein 2 | Up |  ×  |  ×  | Proliferative lupus nephritis, renal cell carcinoma | Endometrial carcinoma |
P01911 | HLA-DRB1 | HLA class II histocompatibility antigen, DRB1 beta chain | Up |  ×  |  ×  | Renal allograft rejection |  ×  |
P01009 | SERPINA1 | Alpha-1-antitrypsin | Up |  ×  |  ×  | Preeclampsia, primary nephrotic syndrome, respiratory pathologies, bladder cancer, prostate cancer, morquio syndrome, hypertension | Bladder cancer, oral cancer, pancreatic cancer, non-small-cell lung cancer |
P02671 | FGA | Fibrinogen alpha chain | Up |  ×  |  ×  | Prostate cancer, bladder cancer, renal allograft rejection | Prostate cancer, bladder cancer |
O14745 | SLC9A3R1 | Na( +)/H( +) exchange regulatory cofactor NHE-RF1 | Up |  ×  |  ×  |  ×  | Hepatocellular carcinoma |
Q10588 | BST1 | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 | Up |  ×  |  ×  | Polycystic and other chronic kidney diseases, chronic lung allograft dysfunction | Prostate cancer |
O75309 | CDH16 | Cadherin-16 | Up |  ×  |  ×  | Sepsis-induced acute kidney injury | Papillary thyroid cancer, lung adenocarcinoma |
P31997 | CEACAM8 | Carcinoembryonic antigen-related cell adhesion molecule 8 | Up |  ×  |  ×  |  ×  | Oral squamous cell carcinoma, non-small cell lung cancer, gastric cancer |
Q9UKK9 | NUDT5 | ADP-sugar pyrophosphatase | Up |  ×  |  ×  |  ×  | Breast cancer, colon cancer |
Q9UN74 | PCDHA4 | Protocadherin alpha-4 | Up | √ |  ×  |  ×  | Cervical cancer |
Q13705 | ACVR2B | Activin receptor type-2B | Down |  ×  | √ |  ×  | Colorectal cancer |
Q6FHJ7 | SFRP4 | Secreted frizzled-related protein 4 | Down |  ×  |  ×  |  ×  | Endometrial carcinoma, bladder cancer, gastric cancer, colon cancer |
O43278 | SPINT1 | Kunitz-type protease inhibitor 1 | Down |  ×  |  ×  | Urothelial carcinoma | Prostate adenocarcinoma, cervical cancer, |
 |  |  |  |  |  |  | Endometrial carcinoma, CLL, pancreatic ductal adenocarcinoma |
O43291 | SPINT2 | Kunitz-type protease inhibitor 2 | Down |  ×  |  ×  |  ×  | Cervical cancer, endometrial carcinoma, breast cancer, prostate cancer |
P08174 | CD55 | Complement decay-accelerating factor | Down |  ×  |  ×  | Respiratory pathologies, prostate cancer | Colon cancer, primary gallbladder carcinoma, bladder cancer |
P09131 | SLC10A3 | P3 protein | Down |  ×  |  ×  |  ×  |  ×  |
P09486 | SPARC | SPARC | Down |  ×  |  ×  | Clear cell renal cell carcinoma, urinary bladder cancer | Rectal cancer, non-small-cell lung cancer, pancreatic cancer, gastric cancer, hypopharyngeal cancer, colon cancer, diffuse large B-cell lymphoma, breast cancer |
P13598 | ICAM2 | Intercellular adhesion molecule 2 | Down |  ×  |  ×  |  ×  | Lung cancer |
P15151 | PVR | Poliovirus receptor | Down |  ×  |  ×  |  ×  | Multiple myeloma, bladder cancer |
P16112 | ACAN | Aggrecan core protein | Down |  ×  |  ×  |  ×  | Gastric cancer, breast cancer |
P19022 | CDH2 | Cadherin-2 | Down |  ×  |  ×  | Respiratory pathologies, diabetic nephropathy | Malignant bone and soft tissue tumors, ductal carcinoma, glioblastoma, papillary thyroid carcinoma |
P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Down |  ×  |  ×  | Rheumatoid arthritis, adult-onset Still's disease | colorectal cancer, cervical cancer, cholangiocarcinoma, papillary thyroid carcinoma, liver cancer |
P20138 | CD33 | Myeloid cell surface antigen CD33 | Down |  ×  |  ×  |  ×  | Colorectal cancer, AML |
P30530 | AXL | Tyrosine-protein kinase receptor UFO | Down | √ |  ×  |  ×  | Osteosarcoma, melanoma, esophageal adenocarcinoma, non-small cell lung cancer, colorectal adenocarcinoma, Wilms' tumor |
Q15043 | SLC39A14 | Metal cation symporter ZIP14 | Down |  ×  |  ×  |  ×  | Colorectal cancer, prostate cancer, breast cancer |
Q9HBB8 | CDHR5 | Cadherin-related family member 5 | Down |  ×  |  ×  | Autism | Hepatocellular carcinoma, clear cell renal cell carcinoma, pancreatic ductal adenocarcinoma |
Q9NU53 | GINM1 | Glycoprotein integral membrane protein 1 | Down |  ×  |  ×  | Bladder carcinoma | Bladder carcinoma |
Q9ULK6 | RNF150 | RING finger protein 150 | Down |  ×  |  ×  |  ×  |  ×  |
Q9Y4C0 | NRXN3 | Neurexin-3 | Down |  ×  |  ×  |  ×  | Glioblastoma |
O75339 | CILP | Cartilage intermediate layer protein 1 | Down |  ×  |  ×  | Cartilage matrix turnover | Bladder cancer |
Q9H6X2 | ANTXR1 | Anthrax toxin receptor 1 | Down |  ×  |  ×  |  ×  | Angiosarcoma, gastric cancer, colorectal cancer, lung cancer |
P43490 | NAMPT | Nicotinamide phosphoribosyltransferase | Down | √ |  ×  |  ×  | Glioblastoma, bladder cancer, breast cancer, prostate cancer, basal cell carcinomas, breast invasive ductal carcinoma |
Q9BXN2 | CLEC7A | C-type lectin domain family 7 member A | Down |  ×  |  ×  |  ×  | Clear cell renal cell carcinoma, AML |